
December 2, 2024
Gaithersburg’s Shuttle Pharma Begins Phase 2 Trial of Ropidoxuridine for Glioblastoma at UVA Cancer Center
GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…